In this episode, we explore the impact of two groundbreaking technologies in genetic engineering - cloning and CRISPR/Cas9. We begin by discussing the controversy surrounding human cloning, including the claim by several fertility doctors that they plan to clone a human baby. We also examine the case of Brigitte Boisselier, who announced the birth of the first human clone, called Eve, in 2002. We discuss the potential costs and implications of clandestine human cloning and why cloning camels and pets has become a lucrative business.
We then shift our focus to CRISPR/Cas9, a revolutionary gene editing technology that allows for precise changes to genomic DNA. We discuss the work of CRISPR Therapeutics, a leading gene editing company that aims to develop transformative gene-based medicines for serious diseases. We explore the potential implications of this technology and its potential to transform healthcare.
Finally, we reflect on the movie "Gattaca," which explores a future where genetic engineering has become the norm. We discuss the implications of this movie for our understanding of genetic engineering and how it might shape our future. Overall, this episode provides a comprehensive overview of the current state of genetic engineering and its potential for both good and bad.
